
Edwards Lifesciences Corporation EW
$ 82.62
-0.35%
Annual report 2025
added 02-25-2026
Edwards Lifesciences Corporation Operating Expenses 2011-2026 | EW
Annual Operating Expenses Edwards Lifesciences Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 1.99 B | 1.71 B | 1.54 B | 1.38 B | 1.23 B | 1.21 B | 1.07 B | 997 M | 889 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.99 B | 889 M | 1.34 B |
Operating Expenses of other stocks in the Medical devices industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Helius Medical Technologies
HSDT
|
12.5 M | $ 2.22 | 2.55 % | $ 1.35 M | ||
|
OrthoPediatrics Corp.
KIDS
|
212 M | $ 17.26 | 1.29 % | $ 405 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | ||
|
LivaNova PLC
LIVN
|
697 M | $ 66.29 | 15.11 % | $ 3.62 B | ||
|
Myomo
MYO
|
41.3 M | $ 0.84 | -4.25 % | $ 35.2 M | ||
|
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | ||
|
Orthofix Medical
OFIX
|
344 M | $ 12.33 | -0.88 % | $ 488 M | ||
|
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | ||
|
Alphatec Holdings
ATEC
|
614 M | $ 7.12 | -30.45 % | $ 1.07 B | ||
|
EDAP TMS S.A.
EDAP
|
20.8 M | $ 3.56 | 3.04 % | $ 133 M | ||
|
Aziyo Biologics
AZYO
|
33.5 M | - | 1.37 % | $ 20.5 M | ||
|
Insulet Corporation
PODD
|
531 M | $ 150.99 | -9.88 % | $ 10.6 B | ||
|
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | ||
|
BioSig Technologies
BSGM
|
71.1 M | - | 37.08 % | $ 85.7 M | ||
|
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | ||
|
Sintx Technologies
SINT
|
11.2 M | $ 2.47 | 1.86 % | $ 6.85 M | ||
|
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | ||
|
Stryker Corporation
SYK
|
11.2 B | $ 291.1 | -1.42 % | $ 111 B | ||
|
ClearPoint Neuro
CLPT
|
15.3 M | $ 11.61 | 4.59 % | $ 329 M | ||
|
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | ||
|
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | ||
|
TransMedics Group
TMDX
|
254 M | $ 71.46 | -24.72 % | $ 2.43 B | ||
|
Tandem Diabetes Care
TNDM
|
159 M | $ 18.18 | -6.39 % | $ 1.24 B | ||
|
Cytosorbents Corporation
CTSO
|
41.2 M | $ 0.58 | -3.93 % | $ 36.1 M | ||
|
Delcath Systems
DCTH
|
72.8 M | $ 11.38 | -1.34 % | $ 408 M | ||
|
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M | ||
|
IRIDEX Corporation
IRIX
|
21.8 M | $ 1.03 | -1.9 % | $ 17.4 M | ||
|
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
126 M | - | - | $ 10.2 M | ||
|
Varex Imaging Corporation
VREX
|
318 M | $ 11.95 | 3.6 % | $ 495 M | ||
|
Electromed
ELMD
|
40.3 M | $ 26.01 | 0.76 % | $ 220 M | ||
|
Vivos Therapeutics
VVOS
|
30.4 M | $ 0.71 | 0.65 % | $ 7.29 M | ||
|
Butterfly Network
BFLY
|
123 M | $ 4.66 | -3.32 % | $ 986 M | ||
|
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | ||
|
Second Sight Medical Products
EYES
|
27.6 M | - | -0.97 % | $ 54.4 M | ||
|
GBS
GBS
|
12.7 M | - | -0.57 % | $ 7.12 M | ||
|
Globus Medical
GMED
|
547 M | $ 89.64 | -0.43 % | $ 12.1 B | ||
|
CONMED Corporation
CNMD
|
648 M | $ 36.89 | 0.68 % | $ 1.14 B | ||
|
Inspire Medical Systems
INSP
|
240 M | $ 46.24 | -4.17 % | $ 1.36 B | ||
|
Integer Holdings Corporation
ITGR
|
279 M | $ 86.32 | 0.55 % | $ 3 B | ||
|
Invacare Corporation
IVC
|
260 M | - | - | $ 24.7 M |